Medacta Group SA
SIX:MOVE

Watchlist Manager
Medacta Group SA Logo
Medacta Group SA
SIX:MOVE
Watchlist
Price: 170.2 CHF 1.79% Market Closed
Market Cap: CHf3.4B

Gross Margin

72.8%
Current
Improving
by 1.2%
vs 3-y average of 71.6%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
72.8%
=
Gross Profit
€436.4m
/
Revenue
€646.1m

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
72.8%
=
Gross Profit
CHf436.4m
/
Revenue
€646.1m

Peer Comparison

Country Company Market Cap Gross
Margin
CH
Medacta Group SA
SIX:MOVE
3.4B CHF
Loading...
US
Abbott Laboratories
NYSE:ABT
188.5B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
173.6B USD
Loading...
US
Stryker Corp
NYSE:SYK
138.1B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
135.7B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
134.2B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58.9B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.1B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
50.8B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
47.9B USD
Loading...
US
Resmed Inc
NYSE:RMD
37B USD
Loading...

Market Distribution

Higher than 78% of companies in Switzerland
Percentile
78th
Based on 957 companies
78th percentile
72.8%
Low
-13 700% — 34.9%
Typical Range
34.9% — 65.3%
High
65.3% — 137.7%
Distribution Statistics
Switzerland
Min -13 700%
30th Percentile 34.9%
Median 49.4%
70th Percentile 65.3%
Max 137.7%

Medacta Group SA
Glance View

Market Cap
3.4B CHF
Industry
Health Care

Medacta Group SA, hailing from the picturesque setting of Castel San Pietro, Switzerland, stands as a prominent player in the global medical technology arena. Founded in 1999, the company has capitalized on a family-driven passion for innovation and precision in the orthopedic industry. Guided by its roots, Medacta designs and supplies orthopedic implants and surgical instruments, with a staunch focus on products for joint replacement, spine surgery, and sports medicine. But beyond mere manufacturing, Medacta combines cutting-edge research with in-depth medical training programs, ensuring that healthcare professionals are not only equipped with superior products but also with the necessary skills to optimize patient outcomes. The company’s MyPractice Development Plan exemplifies this by pairing technical support with educational efforts, fostering both confidence and competence among its professional clients. Medacta’s business model is a synthesis of product sales and continuous practitioner engagement. Revenue streams primarily flow from the direct sale of their extensive product portfolio, including implants and surgical instruments, to hospitals and surgical centers. However, Medacta's strategy extends its competitive advantage by nurturing strong relationships with medical professionals through training and support initiatives. This symbiotic approach ensures a feedback loop that not only tailors their offerings to the evolving needs of the marketplace but also solidifies client loyalty. Their innovative and educational initiatives secure a unique position in the market, allowing Medacta to maintain a balance of economic success and industry leadership by focusing on quality, innovation, and education.

MOVE Intrinsic Value
HIDDEN
Show
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
72.8%
=
Gross Profit
€436.4m
/
Revenue
€646.1m
What is Medacta Group SA's current Gross Margin?

The current Gross Margin for Medacta Group SA is 72.8%, which is above its 3-year median of 71.6%.

How has Gross Margin changed over time?

Over the last 3 years, Medacta Group SA’s Gross Margin has increased from 70.8% to 72.8%. During this period, it reached a low of 67.5% on Jul 30, 2025 and a high of 70.8% on May 30, 2022.

Back to Top